Biotech giant Illumina will unwind takeover of cancer-screening company Grail

SAN DIEGO, Calif. (AP) — Biotech giant Illumina says it will undo its $7.1 billion purchase of the cancer-screening company Grail after losing …

Do you trust this headline?

Based on recent headline ratings, 89% of this readership currently trusts the local media, which has an average score of 85% regionally and is currently trending positive.

89%

Media Trust Score89%